<DOC>
	<DOCNO>NCT01061268</DOCNO>
	<brief_summary>To evaluate safety efficacy BLINK™ tear compare NO topical artificial tear use improve subject 's visual performance reduce ocular symptom discomfort subject undergone cataract surgery implant Tecnis™ diffractive multifocal intraocular lens ( IOL ) .</brief_summary>
	<brief_title>A Clinical Evaluation Pilot Study Efficacy Blink® Tears Lubricant Eye Drops Relief Dry Eye Symptoms Following Implantation Tecnis® Multifocal Introcular Lens</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Male female subject , 21 year age old Written , inform consent HIPPA Authorization Has 20/40 well best correct visual acuity surgical eye Day 1 postop visit ( Visit 3 ) Has undergo cataract surgery one eye receive Tecnis multifocal intraocular lens study eye . Patients currently use artificial tear regularly , use low viscosity tear symptom relief ( Refresh Tears , Visine Tears , Tears Naturelle , etc . ) Likely complete entire course study . Use systemic ocular medication may affect vision Acute chronic disease illness would increase risk confound study result ( e.g . diabetes mellitus , immunocompromised , etc . ) Subjects diabetes mellitus Uncontrolled systemic ocular disease History ocular trauma prior ocular surgery Amblyopia strabismus Known pathology may affect visual acuity ; particularly retinal change affect vision ( macular degeneration , cystoid macular edema , proliferative diabetic retinopathy , etc . ) Diagnosed degenerative visual disorder ( e.g . macular degeneration , retinal disorder ) predict cause future acuity loss level 20/30 bad Subjects may expect require retinal laser treatment surgical intervention Capsule zonular abnormality may affect postoperative centration tilt lens ( e.g . pseudoexfoliation syndrome ) Pupil abnormality ( nonreactive , tonic pupil , abnormally shape pupil , pupil dilate least 4.0 mm mesopic/scotopic condition ) Contact lens usage within 6 month PMMA contact lenses , 1 month gas permeable lens 1 week extendedwear dailywear soft contact lenses A subject whose bestcorrected visual acuity bad 20/40 surgical eye A subject UNCONTROLLED systemic disease . A potential subject therapy systemic disease yet stabilize consider entry study A subject require use artificial tear supplement , vasoconstrictor and/or redness reliever ocular drop 28 day prior study period A subject require use cyclosporine ocular drop 3 month prior study period A subject active ocular inflammation corneal edema beyond expect Day 1 cataract surgery study eye A subject history conjunctivitis ocular infection study eye within past 3 month , history keratorefractive surgery study eye within past 6 month entry study A subject punctual plug ( ) , intracanalicular plug ( ) history punctual cautery study eye</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Relief dry eye symptom follow implantation TMF IOL</keyword>
</DOC>